Introduction {#s0005}
============

Prior to zygotic genome activation (ZGA), embryonic development is dependent on maternally inherited RNAs and proteins ([@bib2; @bib6; @bib7; @bib33]). In the mouse, there are two waves of ZGA: a minor one at the late zygote stage and a major one at the 2-cell stage ([@bib10; @bib19]). Despite this early ZGA, maternal factors are recognised as essential for embryo viability and also lineage segregation ([@bib17; @bib38]). Maternal factors can either rescue or significantly delay development of the mutant phenotype in zygotic knockout embryos ([@bib1; @bib18; @bib26]). It is therefore important to consider the contribution of both maternal and zygotic gene expression to embryo development, particularly at the pre-implantation stages.

The first lineage segregation in the mouse embryo leads to separation of inside and outside cells that occurs in two cell division waves: at the 8--16 cell and 16--32 cell transition ([@bib4; @bib12; @bib16; @bib23]). Inside and outside cells will develop their unique identity due to their differential position and due to asymmetric partitioning of cell polarity proteins, such as Par1, Par3, aPKC, Jam1, Ezrin and transcripts, such as *Cdx2* ([@bib20; @bib22; @bib27; @bib30; @bib31; @bib35]). Together differential partitioning of key cellular components and differential cell positioning establish the inside--outside asymmetry within the embryo that leads to development of the ICM and TE lineages.

Cdx2 is an essential transcription factor for the development of the mouse embryo at many developmental stages ([@bib11; @bib13; @bib21; @bib28; @bib34; @bib37]). During pre-implantation development, Cdx2 is essential for the TE lineage, but the stage of development at which Cdx2 plays a role and the processes it controls both remain unclear. Embryos with zygotic deletion of *Cdx2* develop normally until the late blastocyst stage leading to the suggestion that Cdx2 is involved only in maintenance of the TE lineage ([@bib25; @bib29]). However, down-regulation of both maternal and zygotic *Cdx2* expression by RNAi or morpholino treatments results in a much earlier phenotype that includes defects in cell polarisation, developmental arrest ([@bib14]) and the abnormal activity of mitochondria ([@bib36]). These studies led to the suggestion that Cdx2 might have two roles in pre-implantation development: first, to ensure appropriate cell polarisation that is critical for TE formation and second, the subsequent maintenance of the TE lineage.

Functionality of maternal Cdx2 was recently questioned as embryos in which maternal *Cdx2* expression was genetically eliminated developed normally ([@bib5]). Here, to address this discrepancy we have genetically ablated both maternal and zygotic *Cdx2* and filmed development of *Cdx2* maternal-zygotic and *Cdx2* maternal and *Cdx2* zygotic knockout embryos side-by-side to compare development to the blastocyst stage. This revealed that embryos deficient for both maternal and zygotic *Cdx2* show significantly reduced developmental potential and increased cell death from the morula stage onwards. The developmental lethality is significantly stronger following depletion of both maternal and zygotic pools of Cdx2, rather than when only maternal or only zygotic Cdx2 are eliminated. Together, these results lead us to conclude that both maternal and zygotic Cdx2 are important for the development of the mouse embryo and that the first stage of development at which Cdx2 plays a role is at the morula stage when specification of the TE first starts.

Materials and methods {#s0010}
=====================

Mouse strains {#s0015}
-------------

To obtain oocytes depleted of maternal *Cdx2*, we used females heterozygous for a *floxed Cdx2* gene ([@bib11]) and a *Cdx2* deletion (Cdx2Δ), and carrying a *Zp3-Cre* transgene ([@bib9]) (*Cdx2*^*loxP*^/*Cdx2Δ*; *Zp3-Cre* females). These females were mated with *Cdx2*^*loxP*^/*Cdx2Δ* males ([Fig. 1](#f0005){ref-type="fig"}). The *Cdx2*^*loxP*^ line ([@bib11]) was a kind gift from Klaus H Kaestner. Complete cleavage of the Cdx2^loxP^ allele in the female germline by Cre recombinase results in 100% of mature oocytes carrying the Cdx2Δ. 50% of the resulting embryos that are *Cdx2Δ*/*Cdx2Δ* are maternal-zygotic knockouts (MZ-KO) and the 50% *Cdx2Δ*/*Cdx2*^*loxP*^ embryos that have a wild-type (but floxed) paternal *Cdx2* allele are heterozygous maternal knockouts (M-KO). Control females were either *Cdx2*^*loxP*^ homozygotes or *Cdx2*^*loxP*^/*Cdx2Δ* heterozygotes and did not carry the *Zp3-Cre* transgene. To obtain embryos depleted of zygotic Cdx2 (Z-KO), mice heterozygous for the *Cdx2* targeted mutation *Cdx2*^*tm1Fbe*^ that we refer to as *Cdx2-* were intercrossed (MGI:1857928) ([@bib8]).

Embryo recovery, culture and time-lapse microscopy {#s0020}
--------------------------------------------------

Mouse embryos were recovered from oviducts of superovulated females (10 IU PMSG, 10 IU hCG; Intervet), collected into M2 medium with 4 mg/ml BSA, and cultured in KSOM supplemented with 4 mg/ml BSA as described before ([@bib15]). To record the development of each individual embryo, embryos were cultured on gridded dishes and filmed by time-lapse microscopy. Imaging was non-invasive and carried out using a wide-field Zeiss microscope with a Hamamatsu Orca ER digital camera and DIC *Z*-stacks were collected at 15 min intervals for 58 h.

To analyse any occurrence of cell death during embryo development, SYTOX fluorescent green nucleic acid stain (Life technologies) was added to the culture medium as previously described ([@bib3]).

Individual embryo immunofluorescence and genotyping {#s0025}
---------------------------------------------------

Individual embryos were removed from the gridded dish upon completion of time-lapse imaging, fixed individually in 4% PFA (4 °C, 12 h) and processed for immunofluorescence as previously described ([@bib24]). Primary antibodies: mouse anti-Cdx2 (BioGenex; 1:200), rat TROMA-1 anti-cytokeratin-8 (DSHB, Iowa; 1:100); and rabbit anti-Nanog (R&D Systems; 1:200). DNA was stained with Hoechst (Sigma). Images were recorded using a Leica SP5 confocal microscope with a 40× oil objective.

Following immunofluorescence, the genotype of each embryo was determined by PCR. To this end, genomic DNA was extracted from individual embryos in 10 µl extraction/neutralization buffers ([@bib32]). 4.5--5 µl of the lysate was used in PCR reactions using the Fast Cycling PCR Kit (Qiagen) and primers: 5′-GACCGAAGTCTGCAGAACCT and 5′-GGCTCAGGACTTGCTCCTTCA to detect Cdx2 WT and Cdx2 KO alleles; and 5′-AGCCCATTGCTGGACGGAGG and 5′-CCGCTTACCTTGACGCCACA to detect cleaved KO (null) allele.

Results {#s0030}
=======

Cdx2 is required for correct development to the blastocyst stage *in vivo* {#s0035}
--------------------------------------------------------------------------

The stage at which Cdx2 is first required for development of the mouse embryo remains unclear because Cdx2 is expressed both maternally and zygotically ([@bib14; @bib36]). To address this, we used a genetic approach to deplete maternal and zygotic pools of Cdx2 from the oocyte stage onwards by crossing females heterozygous for a *floxed Cdx2* gene and a *Cdx2* deletion and carrying the *Cre*-*recombinase* gene under control of the *ZP3 promotor* (*Cdx2*^*loxP*^/*Cdx2Δ*; *Zp3-Cre*) with *Cdx2*^*loxP*^/*Cdx2Δ* males ([Fig. 1](#f0005){ref-type="fig"}). This cross results in equal proportions of homozygotes for the *Cdx2* deletion and heterozygotes with one deleted copy and one *floxed* copy. We first allowed the embryos to develop *in utero* and recovered them 3.75 days after fertilisation when they should have reached the mature blastocyst stage. To ensure that the embryos were of the highest possible quality, embryos were recovered from naturally mated rather than super-ovulated females. We found that none of the *Cdx2* maternal-zygotic knockout embryos (0 out of 8, 0%) developed to the blastocyst stage ([Fig. 2](#f0010){ref-type="fig"}A). This was in contrast to their heterozygous siblings, *Cdx2* maternal-knockout embryos, where 6 out of 10 (60%) embryos developed to the blastocyst stage. In a control group of embryos from *Cdx2*^*loxP*^/*Cdx2*^*loxP*^ mothers lacking the ZP3-Cre transgene, 15 out of 17 (88%) progressed to the blastocyst stage. Thus, deficiency of maternal and zygotic *Cdx2* expression leads to an earlier lethal phenotype than observed for the *Cdx2* zygotic knockout alone when embryos develop normally until the late blastocyst stage ([@bib25; @bib29]). These results indicate a role for maternally provided *Cdx2* in development before the blastocyst stage.

Cdx2 is required for the morula to blastocyst stage transition *in vitro* {#s0040}
-------------------------------------------------------------------------

To determine the exact stage of the developmental arrest of *Cdx2* maternal-zygotic knockout embryos, we next wished to monitor their progression from the 2-cell stage until the blastocyst stage. In order to observe the developing embryos continuously, we used time-lapse microscopy. Individual embryos were allocated to individual interstices of grids in a culture chamber so that the development of each embryo could be tracked before being genotyped. This allowed us to gather as much information as possible about successive stages of pre-implantation development of all individually genotyped embryos ([Fig. 2](#f0010){ref-type="fig"}B). We found that from 32 *Cdx2* maternal-zygotic knockout embryos, 69% arrested development at the morula stage (*Cdx2Δ*/*Cdx2Δ* embryos from *Cdx2*^*loxP*^/*Cdx2Δ*; *Zp3-Cre* mothers; [Fig. 2](#f0010){ref-type="fig"}C), in agreement with our *in vivo* experiments above. This was in contrast to *wild-type* embryos of which 90% (*N*=10) developed to the blastocyst stage (Control group 2, progeny of *Cdx2*^*loxP*^/*Cdx2*^*loxP*^ parents; [Figs. 2](#f0010){ref-type="fig"}C; *p*=0.002, 2-tail Fisher exact test). We found that 55% (*N*=20) of *Cdx2* maternal only knockout embryos (*Cdx2*^*loxP*^/*Cdx2Δ*) arrested at the morula stage, in contrast to only 14% of *Cdx2* zygotic only knockout embryos obtained by *Cdx2*+/− intercrosses (*Cdx2−*/*−*, Control group 3; *N*=7). Together these results suggest that maternal Cdx2 contributes to normal development from the morula to the blastocyst stage.

Cell death in maternal and zygotic Cdx2 knockout embryos {#s0045}
--------------------------------------------------------

In order to understand the developmental failure of *Cdx2* maternal-zygotic knockout embryos, we analysed time-lapse recordings. This revealed that while in *wild-type* embryos cell death does not occur until the late blastocyst stage, in *Cdx2* maternal-zygotic knockout embryos cell death occurs much earlier, at the morula stage ([Fig. 2](#f0010){ref-type="fig"}D, arrows). To confirm this observation, we next cultured *Cdx2* maternal and maternal-zygotic knockout embryos in the presence of Sytox, a fluorescent nucleic acid stain which allows detection of cell death *in vivo* by time-lapse microscopy. To ensure that the embryos were of highest possible quality, embryos were recovered from naturally mated rather than super-ovulated *Cdx2*^*loxP*^/*Cdx2Δ*; *Zp3-Cre* females. We analysed development of 25 embryos, from which we were able to genotype 16, from which 10 were *Cdx2* maternal-zygotic knockout embryos and 6 their heterozygous *Cdx2* maternal only knockout siblings (the remaining embryos were lost during procedure or the genotyping result was ambiguous). This revealed that the absence of both maternal and zygotic Cdx2 led to a significantly higher number of dead cells compared to maternal depletion alone (4.1 cells per embryo *versus* 1.7 cells per embryo, respectively; *p*\<0.005, 2-tail Fisher exact test). Together these results indicate that total loss of Cdx2 leads to cell death prior to blastocyst formation.

Cdx2 is required for correct TE specification {#s0050}
---------------------------------------------

In order to determine the effect of depletion of both maternal and zygotic *Cdx2* expression on lineage specification, we examined the expression of two lineage markers; the TE marker cytokeratin-8 (recognised by TROMA-1 antibody) and the ICM marker, Nanog. We found that cytokeratin-8 expression was either totally absent or significantly weaker in *Cdx2* maternal-zygotic knockout embryos in comparison to control embryos ([Figs. 3](#f0015){ref-type="fig"}A and B). Immunostaining also confirmed the loss of the *Cdx2* TE marker, as expected ([Figs. 3](#f0015){ref-type="fig"}A, B, and D). To quantify the decrease in TROMA-1 staining, we have measured the fluorescent signal intensity using ImageJ and an automated macro by which image stacks were convolved with a Gaussian blur to reduce detector noise effects and then thresholded for calculation of the mean intensity. These analyses confirmed a significant decrease in cytokeratin-8 expression in *Cdx2* maternal-zygotic knockout and maternal knockout embryos in comparison to *Cdx2Δ*/*Cdx2*^*loxP*^ and *Cdx2*^*loxP*^/*Cdx2*^*loxP*^ control embryos that developed for the same period of time (*p*\<0.05, Student׳s *t*-test). Immunofluorescence for the ICM marker Nanog in *Cdx2* maternal-zygotic knockout embryos revealed its ectopic expression in outside cells ([Fig. 3](#f0015){ref-type="fig"}C), in agreement with the role of Cdx2 in down-regulating pluripotency genes. These results indicate that Cdx2 is important for the specification of the TE lineage.

Discussion {#s0055}
==========

To address when Cdx2 function is required in early mouse development we have eliminated both maternal and zygotic *Cdx2* expression to determine if this would result in an earlier phenotype than previously reported for *Cdx2* zygotic null embryos, which progress normally to the blastocyst stage ([@bib25; @bib29]). To this end, we have used a ZP3-cre/loxP strategy that eliminates *Cdx2* from the oocyte and time-lapse imaging to record individual embryos throughout pre-implantation development. This revealed that *Cdx2* maternal-zygotic null embryos show significantly reduced developmental potential to the blastocyst stage, increased cell death and failure of the specification of the TE lineage. This lethal phenotype of *Cdx2* maternal-zygotic null embryos occurred irrespective of whether embryos were allowed to develop *in vivo* or *in vitro*. This leads us to conclude that Cdx2 is important for correct development of the pre-implantation embryo due to a role in the specification of TE lineage from the morula stage.

The findings we report here differ from the conclusion of a study examining the consequences of depleting maternal *Cdx2* ([@bib5]). It is unlikely that this difference reflects the effects of embryo culture conditions because we observe the same developmental lethality whether embryos develop *in vivo* or *in vitro*. It is possible that differences in the methods of analysis contributed to the apparent difference in outcome. In assessing developmental potential of *Cdx2* maternal knockout embryos, [@bib5] reported no difference in litter size between wild-type females and maternal knockout females mated to wild-type males (7.3±1.5 and 7.0±0.5, respectively). By contrast, we found that 40% (*N*=10) of embryos deficient for only maternal *Cdx2*, and yet having zygotic expression of *Cdx2*, failed to develop to the blastocyst stage, compared with only 12% (*N*=17) of a control group within the same period of time. When the contribution of both maternal and zygotic *Cdx2* were depleted (*N*=8), we found that none of the embryos developing *in vivo* reached the blastocyst stage.

Another possibility is the number of embryos examined. [@bib5] cultured 11 *Cdx2* maternal-zygotic null and 10 *Cdx2* zygotic null embryos together and reported no differences in their development from the single cell to the blastocyst stage. We made time-lapse recordings of 32 individual *Cdx2* maternal-zygotic and 20 individual maternal null embryos. This revealed that the majority (69%, *N*=32) of the *Cdx2* maternal-zygotic null and 55% (*N*=20) of the maternal null embryos did not reach the blastocyst stage within 3 days of culture starting from the 2-cell stage. In comparison, only 15% of *Cdx2* zygotic null embryos (*N*=7) and 7% of control group embryos (*N*=28) failed to reach the blastocyst stage within the same period of time. These results indicate that Cdx2 is important for efficient development to the blastocyst stage.

Our time-lapse experiments revealed cell death in the *Cdx2* maternal-zygotic null embryos at the morula stage whereas cell death does not occur at this developmental stage in *wild-type* embryos. We also found that the *Cdx2* maternal-zygotic null embryos showed either absent or significantly reduced expression of the classic TE maker cytokeratin-8 together with expression of the pluripotent marker, Nanog, in outside cells, suggesting failure in TE specification, in agreement with earlier Cdx2 down-regulation studies from the 2-cell stage ([@bib14]). Taken together, the findings we report here provide evidence that total depletion of Cdx2 compromises pre-implantation development, both *in vivo* and *in vitro*, and that this is associated with increased cell death and defects in TE specification starting in morula stage embryos. These results lead us to conclude that *Cdx2* is involved in normal embryonic development of the mouse before the blastocyst stage.
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![Breeding schemes used to generate *Cdx2* maternal-zygotic knockout and maternal knockout embryos.](gr1){#f0005}

![(A) Development of Cdx2 maternal-zygotic null embryos in vivo and in vitro. Summary of data on the frequency of blastocyst formation in embryos developing *in utero.* Experimental embryos are progeny of *Cdx2*^loxP^/*Cdx2*∆; *Zp3-cre* mothers, and control group 1 *Cdx2*^loxP^/ *Cdx2*^loxP^ mothers, in both cases crossed to *Cdx2*^loxP^/*Cdx2*∆ fathers. The embryos were recovered at E3.75. The average number of cells were as follows: control embryos (Cdx2^loxP^/Cdx2^loxP^), 60.5; control embryos (Cdx2^loxP^/Cdx2∆), 63.4; maternal knockout embryos (Cdx2^loxP^/Cdx2∆), 43.4; maternal-zygotic knockout embryos (Cdx2∆/Cdx2∆ ), 29.0. Embryo morphology was assessed immediately after recovery after which embryos were fixed, stained and genotyped. (B) Schematic representation of experimental design for culturing, time-lapse imaging and genotyping individual embryos. (C) Summary of data on the frequency of blastocyst formation in embryos developing *in vitro*. Control group 2 is progeny of *Cdx2*^loxP^ parents; control group 3, are embryos from *Cdx2*+/*−* intercrosses. (D) Examples of embryo development from 4-cell to the blastocyst stage in control (upper panel) and maternal-zygotic knockout (MZ-KO) embryos (lower panels). Dying cells indicated with white arrows. Bar=25 μm. (E) Still images of time-lapse recording of pre-implantation development of *Cdx2* MZ-KO (top two panels) and control (bottom panel) embryos. Dying cells are marked by SYTOX, a fluorescent green cell death reporter. Cell death in MZ-KO embryos is initiated at earlier developmental stages than in control embryos and with significantly higher frequency. Bar=25 μm.](gr2){#f0010}

![Aberrant trophectoderm specification in embryos lacking maternal and zygotic expression of *Cdx2*. (A) Expression of trophectoderm (TE) specific cytokeratins, recognised by TROMA-1 antibody, is reduced in *Cdx2* MZ-KO (*N*=6) and M-KO (*N*=7) embryos in comparison to both heterozygous (*N*=4) and homozygous (*N*=4) controls allowed to develop for the same time period (4.5 days post-fertilisation). Fluorescent signal intensity was quantified using ImageJ and the pipeline was automated using a macro. Image stacks in the appropriate channels were convolved with a Gaussian blur (*σ*=2) to reduce the effects of detector noise, then thresholded using Li׳s Minimum Cross Entropy thresholding method. This was applied to areas that include all of the labelled membrane while excluding as much background as possible. The mean intensity value of thresholded areas in the stack was calculated. (B) Representative embryos from the quantitative analysis depicted in A. (C) Ectopic expression of Nanog (white arrows) in outside cells of *Cdx2* maternal-zygotic null (*N*=29) but not in control (Cdx2^loxP^) embryos. (D) Positive Cdx2 antibody control showing immunofluorscent detection of Cdx2 in trophoblast stem (TS) cells (top panel), and negative antibody control in E3.5 blastocyst (bottom panel) showing Cdx2 restriction to outer (TE) cells and omission from the ICM (indicated with dashed line).](gr3){#f0015}
